This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,729 contract is for the delivery of Nuplazid 34 mg capsules by January 3, 2025.
DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This delivery order is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple medical product categories. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides essential pharmaceutical products and services to support the medical needs of military healthcare facilities and veterans' medical centers nationwide.
Generated 3/12/25, 10:08 AM